Skip to main content
Figure 1 | Respiratory Research

Figure 1

From: Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Figure 1

Network of treatments connected by studies for each outcome of interest. A: change from baseline FEV1, L; B: annual rate of exacerbations; C: change from baseline SGRQ Total score. Note: All stated nominal doses are mcg. Connecting lines represent studies included in the model that directly compare the two treatments. The thickness of the line is proportional to the number of studies comparing the two treatments. BDP = beclomethasone dipropionate, BID = twice daily, BUD = budesonide, FORM = formoterol, FF = fluticasone furoate, FP = fluticasone propionate, MMF = mometasone furoate, QD = once daily, SAL = salmeterol, THEO = theophylline, TIO = tiotropium, VI = vilanterol.

Back to article page